1h Free Analyst Time
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Embolic Protection Devices Market ReportSpeak directly to the analyst to clarify any post sales queries you may have.
The market is growing mainly due to the rising cardiovascular and neurovascular diseases across the globe. Globally, such diseases are primarily caused by several factors, including obesity, lack of physical activities, and hypertension. Epidemiological studies have reported that cardiac and neuro diseases are recognized as the leading cause of morbidity and mortality worldwide. Several factors influence the growth of the global embolic protection devices market. The rising demand for cerebral embolic protection devices is expected to drive the growth of the market. Growing demand for cerebral protection while performing neurovascular surgeries such as carotid artery stenting is another driving factor for the global embolic protection devices market.
The following factors are likely to contribute to the growth of the embolic protection devices market during the forecast period:
- Emergence of Advanced Embolic Protection Devices
- New Product Approvals
- Demand for Cerebral Embolic Protection Devices
The study considers the present scenario of the embolic protection devices market and its market dynamics for the period 2019-2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Global Embolic Protection Devices Market Segmentation
The global embolic protection devices market research report includes a detailed segmentation by product, application, indication, end-user, and geography. The filter devices segment accounts for the maximum market share. This is due to effective clinical results for percutaneous and transcatheter surgical techniques to treat cardiac and neuro disorders. It is expected to grow at the highest CAGR owing to greater safety and procedural outcomes. The high success rate and the growing patient pool for several cardiac and neuro diseases is likely to influence segment growth. The filter devices have a larger profile than the occlusion devices segment. Availability of latest-generation devices Such as ANGIOGUARD RX Guidewire System, by Cardinal Health & FilterWire EZ by Boston Scientific, is driving the growth of the filter devices segment.
The cardiac & peripheral segment is expected to retain its market dominance during the forecast period. Filter or occlusion embolic protection devices have proven clinical benefits and can be used when technically feasible for cardiac & peripheral applications. As a result, there is a huge demand for EPDs for treating CVDs across the globe. While APAC is expected to grow at the highest CAGR, North America is likely to retain dominance in the market.
Despite potential growth opportunities of EPDs to treat saphenous vein graft (SVG), the recent eruption of the COVID-19 pandemic is causing unprecedented challenges to perform PCI procedures. The spread of the virus has disrupted daily lives with educational and commercial institutions shutting down across cities or countries and travel and large gatherings prohibited.
Healthcare professionals in hospitals use advanced embolic protection stents for cardiac & peripheral and neuro procedures. The market is growing at a healthy rate primarily due to the higher adoption of latest generation EPDs, as a majority of patients prefer to visit hospitals. The aging population and the increasing pool of patient populations with CVDs and neuro disease are the major factors driving the market growth of the hospital segment.
Segmentation by Product
- Filters
- Occlusions
- Cardiovascular & Peripheral
- Neurovascular
- SVG
- Carotid Artery Diseases
- Others
- Aortic Stenosis
- Peripheral Artery Disease
- Acute Myocardial Infraction
- Hospitals
- Specialty Cardiac Centers
- ASCs
- Freestanding CATH Labs
INSIGHTS BY GEOGRAPHY
North America is the single largest market for embolic protection companies. The region has become strategically important for several prominent vendors, such as Boston Scientific and Abbott. Medtronic embolic protection devices are expected to be innovative as the company is investing significant expenditure in R&D. The US is the major revenue contributor to the market, accounted for a share of 90% in 2019.
Europe is the second-largest market for embolic protection devices and accounted for a share of 34% in 2019. It is growing at a healthy rate and is expected to grow at a similar pace during the forecast period. Germany, France, the UK, Spain, and Italy are the major revenue contributors to this region.
Segmentation by Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Brazil
- Argentina
- Mexico
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
INSIGHTS BY VENDORS
The global embolic protection devices market share is highly concentrated. The market has the presence of few established players holding the majority of the market share. Vendors are offering several filter and occlusion embolic protection devices. They are competing based on factors such as technology advances, safety features, regulatory approvals, marketing strategies, and distribution channels.
Prominent Vendors
- Boston Scientific
- Abbott
- Medtronic
Other Prominent Vendors
- Cardinal Health
- Cardiovascular Systems
- Contego Medical
- InspireMD
- NIPRO
- Silk Road Medical
- Terumo
- Venus Medtech
Investigational Companies
- Cardiotimus
- Filterlex
- Innovative Cardiovascular Solutions
- Protembis
- Transverse Medical
Key Questions Answered
1. What is the market size of the global embolic protection devices market analysis?
2. What are the factors impacting the growth of the embolic protection devices market forecast?
3. What are the drivers, trends, and restraints in the market?
4. Who are the leading vendors and what are their market shares?
Table of Contents
1 Research Methodology2 Research Objectives3 Research Process6 Market at a Glance
4 Scope & Coverage
5 Report Assumptions & Caveats
7 Introduction
8 Market Opportunities & Trends
9 Market Growth Enablers
10 Market Restraints
11 Market Landscape
12 Product
13 Application
14 Indication
15 End-User
16 Geography
17 North America
18 Europe
19 APAC
20 Latin America
21 Middle East & Africa
22 Competitive Landscape
23 Key Company Profiles
24 Other Prominent Vendors
25 Investigational Companies
26 Report Summary
28 Appendix
List Of Exhibits
List Of Tables
Companies mentioned
- Boston Scientific
- Abbott
- Medtronic
- Cardinal Health
- Cardiovascular Systems
- Contego Medical
- InspireMD
- NIPRO
- Silk Road Medical
- Terumo
- Venus Medtech
- Cardiotimus
- Filterlex
- Innovative Cardiovascular Solutions
- Protembis
- Transverse Medical
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
